The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSt. Ives PLC Regulatory News (SIV)

Share Price Information for St. Ives PLC (SIV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.50
Bid: 25.00
Ask: 30.00
Change: 0.00 (0.00%)
Spread: 5.00 (20.00%)
Open: 27.50
High: 27.50
Low: 27.50
Prev. Close: 27.50
SIV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of CEO at Sivota’s subsidiary, Apester

26 Sep 2022 07:10

RNS Number : 5368A
Sivota PLC
26 September 2022
 

26 September 2022

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION REGARDING SIVOTA PLC.  NOTHING IN THIS ANNOUNCEMENT OR THE PROSPECTUS CONSTITUTES AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY SECURITIES IN ANY TERRITORY.

SIVOTA PLC

("Sivota," or "the Company")

Appointment of Chief Executive Officer at Sivota's subsidiary - Apester

Sivota, the London listed investment vehicle focused on later-stage, Israeli technology companies, is pleased to announce the appointment of Itay Gissin as Chief Executive Officer at its subsidiary - Apester Limited ("Apester"). 

On 13 May the Company completed the acquisition of a majority stake in Apester, an Israeli incorporated business which operates an innovative digital experience software platform that enables brands, publishers and e-commerce to create and distribute interactive digital experiences, in relation to a potential transaction. 

Since the acquisition, the Company is implementing a number of strategic and operational changes within Apester. Such changes included the appointment of new board members to Apester, the departure of the founders from their active positions in Apester, and now appointing a new CEO to Apester.

The new appointed CEO Itay Gissin, is an experienced media and technology executive. Itay held a number of senior Executive roles, including as the CEO of Investing.com media company, the SVP of New Business at Webpals, the main operating subsidiary of XLMedia PLC, as well as senior management positions in few Israeli technology start-ups. His vast experience with scaling tech and media businesses and driving sales and marketing for new businesses will help to lead Apester to achieve its strategic goals.

Ziv Ben Barouch, Chief Executive Officer at Sivota, commented:

"We are delighted to welcome Itay to Apester and believe that, with his significant experience in the media sector and proven business development skills, he will lead Apester to execute its plan and capitalise on our growth initiatives.

 Itay's extensive knowledge of the media sector makes him the ideal candidate to lead Apester and we look forward to working with him."

For further information, please visit www.sivotacapital.com or contact:

Sivota PLC

Tim Weller, Non-Executive Chairman

Ziv Ben-Barouch, Chief Executive Officer

via Vigo Consulting

Canaccord Genuity Limited

Alex Aylen - Head of Equities

+ 44 (0) 20 7523 8000

Vigo Consulting

Jeremy Garcia

+ 44 (0)20 7390 0230

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCLAMRTMTMTBTT
Date   Source Headline
26th Jan 20249:00 amRNSAppointment of Auditor
12th Jan 20247:00 amRNSEntry into non-binding term sheet
27th Sep 20239:42 amRNSHalf Year Results
7th Sep 20232:16 pmRNSResults of General Meeting
15th Aug 20237:30 amRNSNotice of General Meeting
8th Aug 20237:00 amRNSAppointment of CEO at Sivota’s subsidiary, Apester
21st Jun 20236:26 pmRNSResult of Annual General Meeting
26th May 20237:00 amRNSNotice of 2023 Annual General Meeting
22nd May 202311:16 amRNSChange of Registered Office
28th Apr 20231:52 pmRNSFinal Results
11th Jan 20237:00 amRNSBusiness update
22nd Nov 20221:17 pmRNSHolding(s) in Company
15th Nov 20229:25 amRNSHolding(s) in Company
14th Nov 20222:34 pmRNSHolding(s) in Company
14th Nov 20222:33 pmRNSHolding(s) in Company
14th Nov 20222:32 pmRNSHolding(s) in Company
14th Nov 20222:31 pmRNSHolding(s) in Company
14th Nov 20222:30 pmRNSHolding(s) in Company
14th Nov 20222:29 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSHalf-year Results
26th Sep 20228:00 amRNSReadmission - Sivota plc
26th Sep 20227:10 amRNSAppointment of CEO at Sivota’s subsidiary, Apester
26th Sep 20227:00 amRNSReadmission
22nd Sep 20222:38 pmRNSReadmission and Publication of Prospectus
22nd Sep 20227:00 amRNSReadmission and Publication of Prospectus
30th Aug 20222:24 pmRNSResult of AGM
17th Aug 20225:42 pmRNSNotice of AGM
30th Jun 20227:00 amRNSFinal Results
13th May 20227:00 amRNSAcquisition of Majority Stake in Apester & Placing
22nd Feb 20227:00 amRNSResults of General Meeting
28th Jan 20227:00 amRNSPosting of Shareholder Circular and Notice of GM
25th Jan 20227:00 amRNSConditional Acquisition of Stake in Apester
7th Dec 20218:23 amRNSRTO Transaction and Suspension of Listing
27th Sep 20218:40 amRNSHalf-year Results
5th Aug 20219:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.